Acetyl Hexapeptide-3 (Argireline) vs Palmitoyl Tetrapeptide-7
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Anti-inflammatory matrikine peptide that reduces IL-6-driven inflammaging for calmer, more youthful skin.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Acetyl Hexapeptide-3 (Argireline)
5–10 %
Palmitoyl Tetrapeptide-7
3–3 %
Frequency
Acetyl Hexapeptide-3 (Argireline)
Once daily
Palmitoyl Tetrapeptide-7
Once daily
Administration
Acetyl Hexapeptide-3 (Argireline)
Topical
Palmitoyl Tetrapeptide-7
Topical
Cycle length
Acetyl Hexapeptide-3 (Argireline)
Ongoing/indefinite
Palmitoyl Tetrapeptide-7
Ongoing/indefinite
Onset speed
Acetyl Hexapeptide-3 (Argireline)
Moderate (1-2 weeks)
Palmitoyl Tetrapeptide-7
Moderate (1-2 weeks)
Evidence level
Acetyl Hexapeptide-3 (Argireline)
Limited human trials
Palmitoyl Tetrapeptide-7
Limited human trials
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Anti-Inflammatory
Anti-Aging
Skin Barrier Support
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
Molecular formula
C35H62N14O11S
Molecular weight
887.0 Da
Half-life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS number
616204-22-9
Palmitoyl Tetrapeptide-7
Molecular formula
C34H62N8O7
Molecular weight
694.9 Da
Half-life
Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
Bioavailability
Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
CAS number
221227-05-0
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
5-10% concentration (cream or serum)
Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effect
Used as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Palmitoyl Tetrapeptide-7
Topical
Under 10 ppm (<0.001%) in finished product
Once or twice daily · Ongoing
Customary leave-on cosmetic use is below 10 ppm of the active peptide [6]. Pal-GQPR is almost always used as a co-active alongside Pal-GHK in the Matrixyl 3000 blend rather than on its own.
~3% trade solution (Matrixyl 3000 blend)
Twice daily · ~2 months
In manufacturer clinical testing the trade-solution blend was applied twice daily for about two months [6]. The ~3% figure refers to the diluted trade solution, which contains only ppm-level active peptide.
Best suited for
Acetyl Hexapeptide-3 (Argireline)
Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Palmitoyl Tetrapeptide-7
Individuals with aging skin showing signs of chronic low-grade inflammation
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking to reduce UV-damage-related skin aging (photoaging)
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for synergistic peptide therapy in Matrixyl 3000 products
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Palmitoyl Tetrapeptide-7
Common
- Mild Redness
- Slight Tingling
- Mild Irritation with Other Actives
- Dryness
Uncommon
- Allergic Contact Dermatitis
Serious
- Paradoxical Inflammatory Response
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Palmitoyl Tetrapeptide-7
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.
Contraindications
- Known hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
- Active skin infections at the application site
- Severely compromised skin barrier with active inflammation requiring medical intervention
- No known systemic contraindications at cosmetic concentrations
Which is right for you?
Choose Acetyl Hexapeptide-3 (Argireline) if...
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Choose Palmitoyl Tetrapeptide-7 if...
- Individuals with aging skin showing signs of chronic low-grade inflammation
- Those seeking to reduce UV-damage-related skin aging (photoaging)
- People looking for synergistic peptide therapy in Matrixyl 3000 products
- Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides